Pathogenesis of high-altitude pulmonary edema -: Inflammation is not an etiologic factor

被引:250
作者
Swenson, ER
Maggiorini, M
Mongovin, S
Gibbs, JSR
Greve, I
Mairbäurl, HH
Bärtsch, P
机构
[1] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Med Serv, Seattle, WA 98195 USA
[2] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Res Serv, Seattle, WA 98195 USA
[3] Univ Zurich Hosp, Dept Internal Med, Med Intens Care Unit, Zurich, Switzerland
[4] Univ London Imperial Coll Sci Technol & Med, Sch Sci Technol & Med, Natl Heart & Lung Inst, London, England
[5] Univ Clin Heidelberg, Dept Med, Div Sports Med, Heidelberg, Germany
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2002年 / 287卷 / 17期
关键词
D O I
10.1001/jama.287.17.2228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The pathogenesis of high-altitude pulmonary edema (HAPE) is considered an altered permeability of the alveolar-capillary barrier secondary to intense pulmonary vasoconstriction and high capillary pressure, but previous bronchoalveolar lavage (BAL) findings in well-established HAPE are also consistent with inflammatory etiologic characteristics. Objectives To determine whether inflammation is a primary event in HAPE and to define the temporal sequence of events in HAPE. Design, Setting, and Participants Case study from July through August 1999 of 10 subjects with susceptibility to HAPE and 6 subjects resistant to HAPE, all of whom are nonprofessional alpinists with previous mountaineering experience above 3000 m. Main Outcome Measures Pulmonary artery pressure measurements and BAL findings at low altitude (490 m) and shortly before or at the onset of HAPE at an altitude of 4559 m. Results Subjects who were HAPE susceptible had higher mean (SD) pulmonary artery systolic blood pressures at 4559 m compared with HAPE-resistant subjects (66 vs 37 mm Hg; P=.004). Despite development of HAPE in the majority of HAPE-susceptible subjects, there were no differences in BAL fluid total leukocyte counts between resistant and susceptible subjects or between counts taken at low and high altitudes. Subjects who developed HAPE had BAL fluid with high concentrations of plasma-derived proteins and erythrocytes, but there was no increase in plasma concentrations of surfactant protein A and Clara cell protein. The chest radiograph score was 12.7 for the 3 HAPE-susceptible subjects who developed HAPE before BAL was performed; they were lavaged within 3 to 5 hours. The remainder of the HAPE-susceptible group was lavaged before edema was apparent on radiographs. However, 6 subjects from the HAPE-susceptible group who developed HAPE on the following day had a score on bronchoscopy of 1.5, which increased to 4.6, reflective of mild pulmonary edema. In HAPE cases, there were no elevations in a number of proinflammatory cytokines and eicosanoid and nitric oxide metabolites. Conclusions Early HAPE is characterized by high pulmonary artery pressures that lead to a protein-rich and mildly hemorrhagic edema, with normal levels of leukocytes, cytokines, and eicosanoids. HAPE is a form of hydrostatic pulmonary edema with altered alveolar-capillary permeability.
引用
收藏
页码:2228 / 2235
页数:8
相关论文
共 56 条
[1]   Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction [J].
Ali, MH ;
Schlidt, SA ;
Chandel, NS ;
Hynes, KL ;
Schumacker, PT ;
Gewertz, BL .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 277 (05) :L1057-L1065
[2]   Effects of inhaled nitric oxide and oxygen in high-altitude pulmonary edema [J].
Anand, IS ;
Prasad, BAK ;
Chugh, SS ;
Rao, KRM ;
Cornfield, DN ;
Milla, CE ;
Singh, N ;
Singh, S ;
Selvamurthy, W .
CIRCULATION, 1998, 98 (22) :2441-2445
[3]   LOCALIZATION OF THE SITES OF PULMONARY VASOMOTION BY USE OF ARTERIAL AND VENOUS OCCLUSION [J].
AUDI, SH ;
DAWSON, CA ;
RICKABY, DA ;
LINEHAN, JH .
JOURNAL OF APPLIED PHYSIOLOGY, 1991, 70 (05) :2126-2136
[4]   EXPERIMENTAL HYDROSTATIC PULMONARY-EDEMA IN RABBIT LUNGS - MORPHOLOGY [J].
BACHOFEN, H ;
SCHURCH, S ;
MICHEL, RP ;
WEIBEL, ER .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04) :989-996
[5]   Urinary leukotriene E4 levels are not increased prior to high-altitude pulmonary edema [J].
Bärtsch, P ;
Eichenberger, U ;
Ballmer, PE ;
Gibbs, JSR ;
Schirlo, C ;
Oelz, O ;
Mayatepek, E .
CHEST, 2000, 117 (05) :1393-1398
[6]   COAGULATION AND FIBRINOLYSIS IN ACUTE MOUNTAIN-SICKNESS AND BEGINNING PULMONARY-EDEMA [J].
BARTSCH, P ;
HAEBERLI, A ;
FRANCIOLLI, M ;
KRUITHOF, EKO ;
STRAUB, PW .
JOURNAL OF APPLIED PHYSIOLOGY, 1989, 66 (05) :2136-2144
[7]   PREVENTION OF HIGH-ALTITUDE PULMONARY-EDEMA BY NIFEDIPINE [J].
BARTSCH, P ;
MAGGIORINI, M ;
RITTER, M ;
NOTI, C ;
VOCK, P ;
OELZ, O .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (18) :1284-1289
[8]  
Bartsch P, 1997, RESPIRATION, V64, P435
[9]   NANOGRAM NITRITE AND NITRATE DETERMINATION IN ENVIRONMENTAL AND BIOLOGICAL-MATERIALS BY VANADIUM(III) REDUCTION WITH CHEMI-LUMINESCENCE DETECTION [J].
BRAMAN, RS ;
HENDRIX, SA .
ANALYTICAL CHEMISTRY, 1989, 61 (24) :2715-2718
[10]   Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema [J].
Busch, T ;
Bärtsch, P ;
Pappert, D ;
Grünig, E ;
Hildebrandt, W ;
Elser, H ;
Falke, KJ ;
Swenson, ER .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (02) :368-373